|
시장보고서
상품코드
1890948
의료용 모르핀 시장 : 투여 경로별, 용도별, 최종사용자별, 제조원별, 농도별, 환자 연령층별, 유통 경로별, 지역별Medical Morphine Market, By Route of Administration, By Application, By End User, By Manufacturing Origin, By Strength, By Patient Age Group, By Distribution Channel, By Geography |
||||||
의료용 모르핀 시장은 2025년에 251억 4,000만 달러로 추정되며, 2032년까지 422억 5,000만 달러에 달할 것으로 전망됩니다. 2025년부터 2032년까지 CAGR은 7.7%로 예측됩니다.
| 보고서 커버 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2024년 | 2025년 시장 규모: | 251억 4,000만 달러 |
| 과거 데이터 대상 기간: | 2020-2024년 | 예측 기간: | 2025-2032년 |
| 예측 기간 2025년부터 2032년까지 CAGR: | 7.70% | 2032년 예측치: | 422억 5,000만 달러 |
세계 의료용 모르핀 시장은 제약 산업에서 중요한 부분을 차지하고 있으며, 주로 통증 관리 및 완화 치료를 위한 모르핀 기반 의약품의 제조, 유통 및 활용에 초점을 맞추고 있습니다. 모르핀은 양귀비 식물에서 추출한 천연 오피오이드 알칼로이드이며, 전 세계 임상 현장에서 중증 통증 완화의 표준으로 사용되고 있습니다. 이 중요한 치료제는 특히 수술 후 관리, 암 치료 및 말기 치료 상황에서 급성 및 만성 통증 상태를 관리하는 데 필수적인 역할을 하고 있습니다.
의료용 모르핀 시장은 속효성 정제, 서방형 제제, 주사제, 경구용 액상 등 다양한 제형으로 구성되어 있으며, 각 제형은 환자의 특정 요구와 임상적 요건을 충족하도록 설계되어 있습니다. 의료진은 환자의 삶의 질을 개선하고 효과적인 통증 관리 프로토콜을 보장하기 위해 모르핀의 강력한 진통 효과에 크게 의존하고 있습니다. 이 시장의 중요성은 단순한 수익 창출을 넘어 전 세계 의료 성과와 환자 복지에 직접적인 영향을 미칩니다. 규제 문제와 오피오이드 중독에 대한 우려에도 불구하고, 의료용 모르핀은 중증 통증 관리에 있어 타의 추종을 불허하는 효과로 인해 현대 의학에서 대체할 수 없는 존재로 남아 있습니다. 업계는 치료 효과를 유지하면서 잠재적 위험을 최소화하기 위해 발전하는 제약 기술, 개선된 전달 메커니즘, 강화된 안전성 프로파일과 함께 계속 진화하고 있습니다.
시장 역학
세계 의료용 모르핀 시장은 국제 의료 시스템 전반에 걸쳐 성장 궤도를 유지하는 여러 가지 강력한 요인에 의해 주도되고 있습니다. 주요 촉진요인은 전 세계적으로 만성 통증 질환, 암 환자 및 수술의 증가로 인해 효과적인 통증 관리 솔루션에 대한 수요가 크게 증가하고 있기 때문입니다. 세계 인구의 고령화로 인해 노인들이 의료 과정에서 보다 집중적인 통증 관리 중재를 필요로 하는 경향이 있기 때문에 이러한 수요는 더욱 증폭될 것입니다. 또한, 신흥국의 의료 인프라 개선과 통증 관리 요법에 대한 접근성 향상도 시장 확대에 크게 기여하고 있습니다. 의료진의 적절한 통증 관리 프로토콜과 치료 중 환자의 편안함의 중요성에 대한 인식이 높아짐에 따라 임상 현장에서 모르핀 사용이 증가하고 있습니다.
그러나 오피오이드 처방에 대한 엄격한 규제 프레임워크, 오피오이드 중독 및 의존성에 대한 우려 증가, 전 세계 규제 당국의 감시 강화 등 시장에는 큰 제약이 존재합니다. 오피오이드 사태로 인해 의료 시스템에서 보다 제한적인 처방 가이드라인이 도입되어 시장 성장을 억제할 수 있습니다. 또한, 대체 통증 관리 요법 및 비오피오이드 진통제의 출현은 기존의 모르핀 기반 치료제에 대한 경쟁적 도전을 불러일으키고 있습니다. 이러한 제약에도 불구하고, 시장 상황에는 큰 기회가 존재합니다. 오남용 방지 제제의 개발은 안전성에 대한 우려를 해결하면서 시장 성장의 유망한 길을 보여주고 있습니다. 개발도상국의 의료 접근성 확대는 특히 통증 관리 인프라가 아직 개발되지 않은 지역에서 미개척 시장 잠재력을 제공하고 있습니다.
본 조사의 주요 특징
- 세계의 의료용 모르핀 시장에 대해 조사 분석했으며, 2024년을 기준 연도, 예측 기간(2025-2032년)의 시장 규모(10억 달러)와 CAGR(연평균 성장률)을 예측한 보고서입니다.
- 각 부문의 잠재적 수익기회를 확인하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
- 시장 촉진요인, 억제요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략에 대한 중요한 정보를 제공합니다.
- 이 보고서는 다음과 같은 매개 변수를 기반으로 세계 의료용 모르핀 시장의 주요 기업 프로파일을 제공합니다. 회사 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략.
- 이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 도와줄 것입니다.
- 이 세계 의료용 모르핀 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 의료용 모르핀 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 가정
- 조사 목적
- 가정
- 약어
제2장 시장 범위
- 보고서 개요
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 환경
- 제품 발매·승인
- PEST 분석
- Porters 분석
- 인수합병 동향
- 업계 동향
제4장 세계의 의료용 모르핀 시장 : 투여 경로별, 2020-2032년
- 경구
- 비경구
- 기타 경로(경피, 좌제, 경비 등)
제5장 세계의 의료용 모르핀 시장 : 용도별, 2020-2032년
- 암관련 통증 관리
- 급성 통증(수술 후, 외상, 심근경색)
- 만성 통증(관절염, 근골격계 질환)
- 완화의료 및 종말기 케어
- 기타 용도(예 : 설사 억제, 기침 억제)
제6장 세계의 의료용 모르핀 시장 : 최종사용자별, 2020-2032년
- 병원 및 진료소
- 외래 수술 센터
- 재택의료/재택 헬스케어 시설
- 기타(재활 센터, 호스피스)
제7장 세계의 의료용 모르핀 시장 : 제조원별, 2020-2032년
- 브랜드 제품
- 제네릭
제8장 세계의 의료용 모르핀 시장 : 농도별, 2020-2032년
- 저용량(10mg 이하)
- 중용량(10mg 이상- 30mg 이하)
- 고용량(30mg 이상)
제9장 세계의 의료용 모르핀 시장 : 환자 연령층별, 2020-2032년
- 소아
- 성인
- 노인
제10장 세계의 의료용 모르핀 시장 : 유통 경로별, 2020-2032년
- 병원 약국
- 소매 약국
- 온라인 약국
제11장 세계의 의료용 모르핀 시장 : 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카 국가
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동 국가
- 아프리카
- 남아프리카공화국
- 북아프리카
- 중앙아프리카
제12장 경쟁 구도
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Mallinckrodt Pharmaceuticals plc
- Sun Pharmaceutical Industries Ltd.
- Johnson and Johnson
- Viatris Inc.
- Hikma Pharmaceuticals plc
- Aurobindo Pharma Ltd.
- Endo International plc
- Mylan N.V.(now Viatris)
- Merck KGaA
- Bristol Myers Squibb Company
- Grunenthal GmbH
- Sanofi S.A.
- AbbVie Inc.
제13장 애널리스트의 추천사항
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제14장 참고문헌 및 조사 방법
- 참고문헌
- 조사 방법
- 출판사 소개
Medical Morphine Market is estimated to be valued at USD 25.14 Bn in 2025 and is expected to reach USD 42.25 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 25.14 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.70% | 2032 Value Projection: | USD 42.25 Bn |
The global medical morphine market represents a critical segment within the pharmaceutical industry, primarily focused on the production, distribution, and utilization of morphine-based medications for pain management and palliative care. Morphine, a naturally occurring opioid alkaloid derived from the opium poppy plant, serves as the gold standard for severe pain relief in clinical settings worldwide. This essential therapeutic agent plays an indispensable role in managing acute and chronic pain conditions, particularly in post-surgical care, cancer treatment, and end-of-life care scenarios.
The medical morphine market encompasses various formulations including immediate-release tablets, extended-release formulations, injectable solutions, and oral liquids, each designed to meet specific patient needs and clinical requirements. Healthcare providers rely heavily on morphine's potent analgesic properties to improve patient quality of life and ensure effective pain management protocols. The market's significance extends beyond mere revenue generation, as it directly impacts global healthcare outcomes and patient welfare. Despite regulatory challenges and concerns surrounding opioid dependency, medical morphine remains irreplaceable in modern medicine due to its unparalleled efficacy in severe pain management. The industry continues to evolve with advancing pharmaceutical technologies, improved delivery mechanisms, and enhanced safety profiles to maintain therapeutic benefits while minimizing potential risks.
Market Dynamics
The global medical morphine market is driven by several compelling factors that sustain its growth trajectory across international healthcare systems. The primary driver stems from the increasing prevalence of chronic pain conditions, cancer cases, and surgical procedures worldwide, creating substantial demand for effective pain management solutions. An aging global population further amplifies this demand, as elderly individuals typically require more intensive pain management interventions throughout their healthcare journey. Additionally, improved healthcare infrastructure in emerging economies and enhanced access to pain management therapies contribute significantly to market expansion. Growing awareness among healthcare professionals regarding proper pain management protocols and the importance of patient comfort during treatment has led to increased morphine utilization in clinical settings.
However, the market faces considerable restraints including stringent regulatory frameworks governing opioid prescriptions, growing concerns about opioid addiction and dependency, and increasing scrutiny from regulatory authorities worldwide. The opioid crisis has prompted healthcare systems to implement more restrictive prescribing guidelines, potentially limiting market growth. Furthermore, the emergence of alternative pain management therapies and non-opioid analgesics presents competitive challenges to traditional morphine-based treatments. Despite these restraints, significant opportunities exist within the market landscape. The development of abuse-deterrent formulations presents promising avenues for market growth while addressing safety concerns. Expanding healthcare access in developing regions offers untapped market potential, particularly in areas where pain management infrastructure is still developing.
Key Features of the Study
- This report provides in-depth analysis of the global medical morphine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global medical morphine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals plc, Sun Pharmaceutical Industries Ltd., Johnson and Johnson, Viatris Inc., Hikma Pharmaceuticals plc, Aurobindo Pharma Ltd., Endo International plc, Mylan N.V. (now Viatris), Merck KGaA, Bristol Myers Squibb Company, Grunenthal GmbH, Sanofi S.A., and AbbVie Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global medical morphine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical morphine market
Market Segmentation
- Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Parenteral
- Other routes (transdermal, suppository, intranasal, etc.)
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Cancer related pain management
- Acute pain (post surgery, trauma, myocardial infarction)
- Chronic pain (arthritis, musculoskeletal disorders)
- Palliative and end of life care
- Other applications (e.g., diarrhea suppression, cough suppression)
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Homecare/Home Healthcare Settings
- Other (rehabilitation centers, hospices)
- Manufacturing Origin Insights (Revenue, USD Bn, 2020 - 2032)
- Branded
- Generic
- Strength Insights (Revenue, USD Bn, 2020 - 2032)
- Low dose (e.g.<=10 mg)
- Medium dose (e.g.10 mg to <=30 mg)
- High dose (30 mg)
- Patient Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric
- Adult
- Geriatric
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Mallinckrodt Pharmaceuticals plc
- Sun Pharmaceutical Industries Ltd.
- Johnson and Johnson
- Viatris Inc.
- Hikma Pharmaceuticals plc
- Aurobindo Pharma Ltd.
- Endo International plc
- Mylan N.V. (now Viatris)
- Merck KGaA
- Bristol Myers Squibb Company
- Grunenthal GmbH
- Sanofi S.A.
- AbbVie Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Medical Morphine Market, By Route of Administration
- Global Medical Morphine Market, By Application
- Global Medical Morphine Market, By End User
- Global Medical Morphine Market, By Manufacturing Origin
- Global Medical Morphine Market, By Strength
- Global Medical Morphine Market, By Patient Age Group
- Global Medical Morphine Market, By Distribution Channel
- Global Medical Morphine Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Medical Morphine Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Other routes (transdermal, suppository, intranasal, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Medical Morphine Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cancer related pain management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Acute pain (post surgery, trauma, myocardial infarction)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chronic pain (arthritis, musculoskeletal disorders)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Palliative and end of life care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Other applications (e.g., diarrhea suppression, cough suppression)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Medical Morphine Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Homecare/Home Healthcare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Other (rehabilitation centers, hospices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Medical Morphine Market, By Manufacturing Origin, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Branded
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Medical Morphine Market, By Strength, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Low dose (e.g.<=10 mg)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Medium dose (e.g.>10 mg to <=30 mg)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- High dose (>30 mg)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Medical Morphine Market, By Patient Age Group, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Medical Morphine Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
11. Global Medical Morphine Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mallinckrodt Pharmaceuticals plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson and Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Viatris Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hikma Pharmaceuticals plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aurobindo Pharma Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Endo International plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan N.V. (now Viatris)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Grunenthal GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
